- Home
- AEVA vs ARWR Comparison
AEVA vs ARWR Comparison
Compare AEVA & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEVA
- ARWR
- Stock Information
- Founded
- AEVA 2019
- ARWR 2003
- Country
- AEVA United States
- ARWR United States
- Employees
- AEVA N/A
- ARWR N/A
- Industry
- AEVA Auto Parts:O.E.M.
- ARWR Biotechnology: Pharmaceutical Preparations
- Sector
- AEVA Consumer Discretionary
- ARWR Health Care
- Exchange
- AEVA Nasdaq
- ARWR Nasdaq
- Market Cap
- AEVA 2.0B
- ARWR 1.8B
- IPO Year
- AEVA N/A
- ARWR 1993
- Fundamental
- Price
- AEVA $32.96
- ARWR $17.26
- Analyst Decision
- AEVA Buy
- ARWR Buy
- Analyst Count
- AEVA 6
- ARWR 8
- Target Price
- AEVA $16.20
- ARWR $43.71
- AVG Volume (30 Days)
- AEVA 3.0M
- ARWR 1.4M
- Earning Date
- AEVA 08-06-2025
- ARWR 08-07-2025
- Dividend Yield
- AEVA N/A
- ARWR N/A
- EPS Growth
- AEVA N/A
- ARWR N/A
- EPS
- AEVA N/A
- ARWR N/A
- Revenue
- AEVA $10,326,000.00
- ARWR $545,209,000.00
- Revenue This Year
- AEVA $94.59
- ARWR $21,924.50
- Revenue Next Year
- AEVA $165.22
- ARWR N/A
- P/E Ratio
- AEVA N/A
- ARWR N/A
- Revenue Growth
- AEVA 95.90
- ARWR 1436.97
- 52 Week Low
- AEVA $2.30
- ARWR $9.57
- 52 Week High
- AEVA $38.80
- ARWR $30.41
- Technical
- Relative Strength Index (RSI)
- AEVA 62.39
- ARWR 64.21
- Support Level
- AEVA $26.22
- ARWR $16.45
- Resistance Level
- AEVA $38.80
- ARWR $17.18
- Average True Range (ATR)
- AEVA 3.80
- ARWR 0.76
- MACD
- AEVA -0.10
- ARWR 0.09
- Stochastic Oscillator
- AEVA 62.37
- ARWR 100.00
About AEVA Aeva Technologies Inc.
Aeva Technologies Inc through its Frequency Modulated Continuous Wave (FMCW) sensing technology, designs a 4D LiDAR-on-chip that, along with its proprietary software applications, has the potential to enable the adoption of LiDAR across broad applications from automated driving to consumer electronics, consumer health, industrial automation, and security application. The company operates in North America, EMEA, and Asia. The company derives the majority of its revenue from North America.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.